Abstract
The recent decade is associated with major breakthroughs in lymphocyte immunotyping. In view of the excellent improvement in chemotherapy results in acute lymphoblastic leukemia (ALL) and the chemotherapy associated mortality, Dr. Lovat and associates studied serially the T-lymphocytes in childhood leukemia1.